Yaming Xi
Impact in
-
- Mesenchymal stem cell research
-
- Acute Myeloid Leukemia Research
- Hemophilia Treatment and Research
Papers in
-
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Retinoids in leukemia and cellular processes 2
-
- Hemophilia Treatment and Research 3
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Zijian Li (11 shared papers)Ting Liu (3 shared papers)Che Chen (3 shared papers)Huanling Zhu (2 shared papers)Shengfu Li (1 shared paper)Ling Gu (1 shared paper)Xiaoxi Lu (2 shared papers)Chunxia Liu (2 shared papers)
- Journals
- Medicine (4 papers)Haemophilia (2 papers)Anti-Cancer Drugs (2 papers)Frontiers in Immunology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yaming Xi
38 papers receiving 194 citations
Peers
Comparison fields: 5 of 54
- Genetics 39
- Hematology 34
- Cancer Research 25
- Molecular Biology 85
- Complementary and alternative medicine 9
Countries citing papers authored by Yaming Xi
This map shows the geographic impact of Yaming Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Xi more than expected).
Fields of papers citing papers by Yaming Xi
This network shows the impact of papers produced by Yaming Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Xi. The network helps show where Yaming Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaming Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 36 | |
| 2 | 2019 | 17 | |
| 3 | 2007 | 16 | |
| 4 | 2011 | 16 | |
| 5 | 2023 | 12 | |
| 6 | 2025 | 10 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 2024 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2019 | 5 | |
| 12 | [Effects of AZT on leukemia cell line KG-1a proliferation and telomerase activity]. | 2012 | 5 |
| 13 | [Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia]. | 2012 | 5 |
| 14 | 2019 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2021 | 3 | |
| 18 | [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs]. | 2007 | 3 |
| 19 | 2025 | 3 | |
| 20 | 2023 | 3 |
About Yaming Xi
Yaming Xi is a scholar working on Molecular Biology, Hematology, Immunology, Genetics and Oncology, having authored 45 papers that have together received 198 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Hemophilia Treatment and Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (39 citations), Hematology (34 citations), Cancer Research (25 citations), Molecular Biology (85 citations) and Complementary and alternative medicine (9 citations). Yaming Xi has collaborated with scholars based in China, United States and France. Frequent co-authors include Zijian Li, Ting Liu, Che Chen, Huanling Zhu, Shengfu Li, Ling Gu, Xiaoxi Lu, Chunxia Liu, Yongmei Liu and Wentong Meng. Their work appears in journals such as Medicine, Haemophilia, Anti-Cancer Drugs, Frontiers in Immunology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.